NASDAQ:CYRX - CryoPort Stock Price, Forecast & News

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

CryoPort Inc (NASDAQ:CYRX) released its quarterly earnings data on Thursday, November, 7th. The consumer goods maker reported ($0.05) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.02. The consumer goods maker had revenue of $9.58 million for the quarter, compared to the consensus estimate of $9.49 million. CryoPort had a negative net margin of 64.63% and a negative return on equity of 26.50%. The company's quarterly revenue was up 81.1% on a year-over-year basis. During the same period in the previous year, the company earned ($0.07) earnings per share. View CryoPort's Earnings History.

CryoPort is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for CryoPort.

CryoPort will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

CryoPort issued an update on its FY 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $33.9-33.9 million, compared to the consensus revenue estimate of $35.11 million.

5 brokerages have issued 12 month target prices for CryoPort's stock. Their forecasts range from $21.00 to $24.00. On average, they anticipate CryoPort's stock price to reach $22.75 in the next year. This suggests a possible upside of 36.2% from the stock's current price. View Analyst Price Targets for CryoPort.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.

News stories about CYRX stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a daily sentiment score of -4.0 on InfoTrie's scale. They also assigned press coverage about the consumer goods maker a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near term. View News Stories for CryoPort.

Some companies that are related to CryoPort include Forward Air (FWRD), Hub Group (HUBG), Echo Global Logistics (ECHO), Roadrunner Transportation Systems (RRTS) and Sino-Global Shipping America (SINO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Gilead Sciences (GILD), Exelixis (EXEL), Micron Technology (MU), Antares Pharma (ATRS), bluebird bio (BLUE), ACADIA Pharmaceuticals (ACAD), Advanced Micro Devices (AMD), Amarin (AMRN), Clovis Oncology (CLVS) and Zynga (ZNGA).

CryoPort's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Fred Alger Management LLC (13.01%), Victory Capital Management Inc. (6.55%), Victory Capital Management Inc. (5.77%), Chevy Chase Trust Holdings Inc. (3.71%), State Street Corp (3.29%) and Janus Henderson Group PLC (1.46%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich. View Institutional Ownership Trends for CryoPort.

CYRX stock was sold by a variety of institutional investors in the last quarter, including Chevy Chase Trust Holdings Inc., Axiom International Investors LLC DE, Bank of Montreal Can, SG Americas Securities LLC, Cubist Systematic Strategies LLC, Taylor Wealth Management Partners, Penbrook Management LLC and Braun Stacey Associates Inc.. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman and Robert Stefanovich. View Insider Buying and Selling for CryoPort.

CYRX stock was acquired by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Victory Capital Management Inc., State Street Corp, Handelsbanken Fonder AB, Roubaix Capital LLC, Victory Capital Management Inc., Fred Alger Management LLC and Bullseye Asset Management LLC. View Insider Buying and Selling for CryoPort.

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRX stock can currently be purchased for approximately $16.70.

CryoPort has a market capitalization of $598.53 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.

The official website for CryoPort is http://www.cryoport.com/.

CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]